Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

BACKGROUND: Single-agent gemcitabine (GEM) is a standard treatment for advanced and metastatic pancreatic cancer. This study examines the question whether GEM-based combination chemotherapy can further improve treatment efficacy. METHODS: A meta-analysis was performed to evaluate randomized trials c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Heinemann, Volker, Boeck, Stefan, Hinke, Axel, Labianca, Roberto, Louvet, Christophe
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2008
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2292732/
https://ncbi.nlm.nih.gov/pubmed/18373843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-82
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki